Laboratory News and Research

RSS

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease.

25 Oct 2021

Predictive language models' underlying function more closely resembles the human brain

In the past few years, artificial intelligence models of language have become very good at certain tasks. Most notably, they excel at predicting the next word in a string of text; this technology helps search engines and texting apps predict the next word you are going to type.

25 Oct 2021

New study reveals how gut microbes may contribute to the beneficial effects of breastfeeding

It is widely acknowledged that breastfeeding benefits the health of infants. However, there is still a lack of solid evidence to document what happens in the gut of breastfed babies and how gut microbes may contribute to these beneficial effects.

25 Oct 2021

A new vaccine approach that could prevent future pandemics

News-Medical speaks to Professor Tomohiro Kurosaki about how he has developed a new vaccine approach that could prevent future pandemics.

25 Oct 2021

Cherwell announces ANT Medikal in Turkey as distributor for Redipor microbiological culture media range

Cherwell Laboratories, manufacturer of Redipor® prepared culture media, announces that it has added ANT Medikal, in Turkey, to its international distribution network for the Redipor range, as part of the company’s continued strategic focus on building its overseas markets.

From Cherwell Laboratories 25 Oct 2021

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

A new study examines the potential binding interaction of the beneficial components of Chaga mushroom with that of the SARS-CoV-2 RBD.

24 Oct 2021

Study findings may lead to new treatments to fight deadly C. difficile infections

A University of California, Irvine-led study suggests that the glucosyltransferase domain (GTD) is an ideal molecular target for therapeutic interventions for Clostridioides difficile infection (CDI). These findings may lead to new treatments to fight this deadly disease.

22 Oct 2021

CDC lab testing identifies deadly bacteria in an aromatherapy spray

Laboratory testing at the U.S. Centers for Disease Control and Prevention (CDC) has identified the bacteria Burkholderia pseudomallei in an aromatherapy spray -; the same type of bacteria that sickened four people in the United States earlier this year.

22 Oct 2021

Study examines effectiveness of BNT162b2 vaccine against Delta variant in adolescents

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2 among adolescents.

22 Oct 2021

Citizen-generated data could help fight antimicrobial resistance

Citizen-generated data could help combat the misuse of medicines and prevent antimicrobial resistance (AMR), says a report by the Global Partnership for Sustainable Development Data (GPSDD).

22 Oct 2021

Study shows immune profile heterogeneity amongst healthy adults

Researchers opted to use single-cell RNA-seq to observe single cells in detail as they encounter a specific antigen.

22 Oct 2021

Bacteria defend themselves against viral predators with exchangeable genetic elements

Bacterial viruses, so-called phages, destroy bacteria. Bacteria are constantly exposed to viral attacks. A research team led by Martin Polz, a microbiologist at the University of Vienna, has now studied how bacteria defend themselves against viral predators.

22 Oct 2021

Researchers find a new way to analyze diseased and healthy cells from brain tumor patients

Scientists studying the most common and aggressive type of brain tumor in adults have discovered a new way of analyzing diseased and healthy cells from the same patient.

22 Oct 2021

Researchers discover how Staphylococcus aureus protects itself against important antibiotic

The skin bacterium Staphylococcus aureus often develops antibiotic resistance. It can then cause infections that are difficult to treat.

21 Oct 2021

Research opens new avenues for topical treatment of skin fibrosis

Collagen, the main component of the skin's extracellular matrix, can cause a pathological condition if it is in excess.

21 Oct 2021

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

The National Institute of Allergy and Infectious Diseases has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

21 Oct 2021

Cell-free DNA can help detect measurable residual disease in children with medulloblastoma

Scientists at St. Jude Children's Research Hospital have shown that cell-free DNA from cerebrospinal fluid (CSF) can be used to detect measurable residual disease (MRD) in children treated for the brain tumor medulloblastoma.

21 Oct 2021

Study reveals dual role of anti-cancer inhibitor

TG2, an enzyme known to help cancers spread more quickly, also plays a role in regulating T-cells, according to a Northwestern Medicine study published in the Journal for Immunotherapy of Cancer.

21 Oct 2021

Novel Einstein-developed strategy successfully suppresses HIV infections in mice

Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice-;offering a path to a functional cure for HIV and other chronic viral infections.

21 Oct 2021

CAR-T cell treatment's efficacy in hematological malignancies predicted by epigenetics

One in five cancers affects blood cells and lymph nodes, causing leukemias and lymphomas, respectively. Although their treatment with drugs has led to a great advance in their cure, there are cases where there is no clinical response or resistance to them is generated.

21 Oct 2021

Laboratory News and Research

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

Predictive language models' underlying function more closely resembles the human brain

New study reveals how gut microbes may contribute to the beneficial effects of breastfeeding

A new vaccine approach that could prevent future pandemics

Cherwell announces ANT Medikal in Turkey as distributor for Redipor microbiological culture media range

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Study findings may lead to new treatments to fight deadly C. difficile infections

CDC lab testing identifies deadly bacteria in an aromatherapy spray

Study examines effectiveness of BNT162b2 vaccine against Delta variant in adolescents

Citizen-generated data could help fight antimicrobial resistance

Study shows immune profile heterogeneity amongst healthy adults

Bacteria defend themselves against viral predators with exchangeable genetic elements

Researchers find a new way to analyze diseased and healthy cells from brain tumor patients

Researchers discover how Staphylococcus aureus protects itself against important antibiotic

Research opens new avenues for topical treatment of skin fibrosis

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

Cell-free DNA can help detect measurable residual disease in children with medulloblastoma

Study reveals dual role of anti-cancer inhibitor

Novel Einstein-developed strategy successfully suppresses HIV infections in mice

CAR-T cell treatment's efficacy in hematological malignancies predicted by epigenetics

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News